Dalotuzumab
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Dalotuzumab?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Dalotuzumab is an anti-IGF1 receptor (IGF1R) humanized monoclonal antibody designed for the potential treatment of various cancers.[1] Common adverse effects include hyperglycemia, nausea, vomiting, and fatigue.[2] Dalotuzumab was developed by Merck and Co., Inc.[3]
Quick Facts Monoclonal antibody, Type ...
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | IGF-1 receptor |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
ECHA InfoCard | 100.205.569 ![]() |
Chemical and physical data | |
Formula | C6528H10086N1730O2018S40 |
Molar mass | 146374.99 g·mol−1 |
![]() ![]() |
Close